43 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
Pneumocystis pneumonia (PCP ... encephalitis • Mycobacterium ... • Disseminated Mycobacterium ... Infections #OIs #HIVAIDS ... IDSA #management #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
Pneumocystis pneumonia (PCP ... encephalitis • Mycobacterium ... • Disseminated Mycobacterium ... Infections #OIs #HIVAIDS ... IDSA #management #pharmacology
Immediate Treatment for Myocardial infraction
#management #pharmacology #medications #treatment #cardiology #mnemonic
Immediate Treatment ... #management #pharmacology ... #medications #treatment ... #cardiology #mnemonic
Pulmonary Infections in HIV-AIDS
Bacterial: 
 • No organism identified, Strep pneumoniae, H. influenzae, S.aureus, Streptococcus Grp
200: CMV, HSV Mycobacterial ... • CD4 < 200: PCP ... Fungal, AFB), TB PCR ... sputum, PCP DFA ... Pulmonary #Infections #HIVAIDS
Radiographic appearances of pulmonary diseases in HIV/AIDS Patients
 • Diffuse Interstitial Infiltrates: Pneumocystis jirovecii, M.tuberculosis, Histoplasma
Hodgkin's lymphoma, Mycobacterium ... Nocardia spp., Mycobacterium ... ID_fellows #HIVAIDS ... diagnosis #chestCT #radiology
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Species: • Mycobacterium ... staining, NAA (PCR ... Tuberculosis Treatment ... Initiating Treatment ... Diagnosis #Management #Treatment
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Species: • Mycobacterium ... staining, NAA (PCR ... Tuberculosis Treatment ... Initiating Treatment ... Diagnosis #Management #Treatment
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
management #algorithm #pharmacology ... #treatment #medications ... #decisionaid #cardiology
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
duration same as for treatment ... Disease Note: Treatment ... IDSA #Prevention #Treatment ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
for effective treatment ... IDSA #Prevention #Treatment ... opportunistic #infections #HIVAIDS ... #pharmacology